Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial

NCT00476619 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped The exclusion criteria were stringent and enrollment was slow.

Conditions

Contrast Induced Nephropathy

Interventions

DRUG: erythropoeitin

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]